April 06, 2018
Rose
Todd Smith and Benjamin Bove are known to have consulted at four pharmaceutical companies that subsequently raised prices on life-saving and other drugs by as much as 4,116 percent. Meanwhile, advocacy groups are asking the Trump administration to override patents on a pricey drug; the definition of "pharmacy" is expanded to help level the playing field; an investigation finds drugmakers flouting a law on disclosing their policies.
from Kaiser Health News https://ift.tt/2Hep6WZ
April 06, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: California’s Aging Population Is A Challenge For Next Governor; Two Out Of Three North Carolinians Who Died Because Of Florence Were 60 Or Older- Viewpoints: Eating Disorders Do Not Discriminate By Gender — Boys Can Get Them, Too
- Perspectives: Physicians Are Not Great At Showing Up To Vote. It’s Time To Change That.
- Black Market For Suboxone Gives Some A Glimpse Of Recovery
- Sexual Assault Often Leaves Anxiety, High Blood Pressure And Other Negative Health Outcomes In Its Wake
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment